PROM1 and neuroblastoma: CD133 was originally described as a marker for hematopoietic stem and progenitor cells [30] and has since been used as a marker of CSCs in numerous malignancies [31,32], including neuroblastoma [32,33,34], and remains the most common marker used to identify CSCs in pediatric malignancies [35].